Showing results (1321-1330 of 2,583) with videos related to

Sort By:
Pageof 259
Molecular Oncology|April 23, 2009
PCDH24-induced contact inhibition involves downregulation of beta-catenin signalingRui Ose, Toshihide Yanagawa, Shun Ikeda, et al.
Molecular Oncology|April 23, 2009
Large-scale genomic analysis of ovarian carcinomasKylie L Gorringe, Ian G Campbell
Molecular Oncology|February 17, 2012
Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesisBjörn Åkerblom, Guangxiang Zang, Zhen W Zhuang, et al.
Molecular Oncology|January 24, 2012
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-responseYu-Li Chen, Ming-Cheng Chang, Chia-Yen Huang, et al.
Molecular Oncology|March 13, 2012
Hormonal therapy in breast cancer: a model disease for the personalization of cancer careShannon Puhalla, Saveri Bhattacharya, Nancy E Davidson
Molecular Oncology|February 25, 2012
The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilitiesMichele De Palma, Douglas Hanahan
Molecular Oncology|February 28, 2012
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cellsHuan-Chih Chiu, Teng-Yuan Chang, Chin-Ting Huang, et al.
Molecular Oncology|June 20, 2019
Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cellsEtienne Buscail, Laurence Chiche, Christophe Laurent, et al.
Molecular Oncology|June 20, 2019
The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modelingMonika Vishnoi, Nikki Haowen Liu, Wei Yin, et al.
Molecular Oncology|June 15, 2019
Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic targetYasutaka Yamada, Mayuko Kato, Takayuki Arai, et al.
Pageof 259